Synthesis And Anticancer Activity Of Some Novel 3-[(2-Substituted-6,7,8,9-Tetrahydro-5H-Cyclohepta[b]Thieno [2,3-d] Pyrimidin-4-YL) Amino] Propan-1-OL

Abstract

Synthesis of novel heterocyclic compounds has gained considerable attention in medicinal chemistry because of their potential therapeutic applications, particularly in cancer research. The present study focuses on the synthesis and evaluation of the anticancer activity of novel 3-[(2-substituted-6,7,8,9-tetrahydro-5H-cyclohepta[b]thieno[2,3-d]pyrimidin-4-yl)amino]propan-1-ol derivatives. The designed compounds incorporate a fused thienopyrimidine scaffold with a substituted cycloheptane ring and a propanol side chain, providing a framework for investigating structure–activity relationships. The synthesized derivatives are intended to be characterized using appropriate analytical and spectroscopic techniques to confirm their chemical structures and purity. Their anticancer potential can be evaluated using suitable in vitro cytotoxicity assays against selected cancer cell lines, with appropriate controls for comparison. The relationship between structural modifications and biological activity may provide insights into the influence of substituents on anticancer effects. This study aims to contribute to the development of novel heterocyclic compounds as potential candidates for further anticancer drug discovery and preclinical investigation.